Mr Jason Charles Fleming

Mr. Jason Charles Fleming is an ENT and Head & Neck Surgeon, highly specialised in head and neck cancer as well as thyroid surgery. He serves as a Senior Clinical Lecturer at the University of Liverpool and is an integral member of the Mersey Head & Neck Oncology Group (MHNORG), which is the research division of the Liverpool Head & Neck Centre (LHNC). He has extensive work in translational and clinical research, focusing particularly on novel cancer therapies, the dysregulation of tumour metabolism as a diagnostic and therapeutic avenue, and the immune biology underlying head and neck cancer.

Mr. Fleming holds significant roles in research and clinical trials, including his position as Co-chief Investigator for the forthcoming national phase III trial, PROTIS (PROton beam Therapy versus Intensity-modulated Radiotherapy for Sinonasal cancer). Additionally, he is the lead author of the forthcoming national UK guidelines for sinonasal malignancies and directs various translational and clinical outcome projects within the LHNC.

His academic contributions extend to teaching at the University of Liverpool, where he lectures on Masters-level modules such as Frontiers in Cancer and Cancer Clinical Trials. Regionally, he serves as the academic representative on the regional training committee, is a member of the pan-Trust surgical robotic steering group, and directs the prestigious Shaun Jackson Head and Neck Surgical Fellowship at Aintree.